Guardant Health
Stock Forecast, Prediction & Price Target
Guardant Health Financial Estimates
Guardant Health Revenue Estimates
Guardant Health EBITDA Estimates
Guardant Health Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $373.65M N/A | $449.53M 20.30% | $563.94M 25.45% | Avg: $812.66M Low: $803.50M High: $824.30M avg. 44.10% | Avg: $991.53M Low: $968.23M High: $1.01B avg. 22.00% | Avg: $1.17B Low: $1.14B High: $1.19B avg. 18.02% | Avg: $1.27B Low: $1.24B High: $1.31B avg. 9.37% |
Net Income
% change YoY
| $-384.77M N/A | $-654.58M -70.12% | $-479.44M 26.75% | Avg: $-336.47M Low: $-381.87M High: $-284.44M avg. 29.82% | Avg: $-299.80M Low: $-480.42M High: $-211.65M avg. 10.89% | Avg: $-249.12M Low: $-257.02M High: $-241.51M avg. 16.90% | Avg: $-216.50M Low: $-223.36M High: $-209.88M avg. 13.09% |
EBITDA
% change YoY
| $-381.89M N/A | $-650.87M -70.43% | $-433.30M 33.42% | Avg: $-663.48M Low: $-672.98M High: $-656.00M avg. -53.12% | Avg: $-809.51M Low: $-829.26M High: $-790.49M avg. -22.00% | Avg: $-955.40M Low: $-978.70M High: $-932.95M avg. -18.02% | Avg: $-1.04B Low: $-1.07B High: $-1.02B avg. -9.37% |
EPS
% change YoY
| -$3.8 N/A | -$6.41 -68.68% | -$4.28 33.22% | Avg: -$2.95 Low: -$3.41 High: -$2.54 avg. 31.10% | Avg: -$2.61 Low: -$4.29 High: -$1.89 avg. 11.52% | Avg: -$2.22 Low: -$2.3 High: -$2.16 avg. 14.72% | Avg: -$1.93 Low: -$1.99 High: -$1.87 avg. 13.09% |
Operating Expenses
% change YoY
| $661.74M N/A | $837.59M 26.57% | $901.62M 7.64% | Avg: $746.26M Low: $737.85M High: $756.95M avg. -17.23% | Avg: $910.51M Low: $889.12M High: $932.72M avg. 22.00% | Avg: $1.07B Low: $1.04B High: $1.10B avg. 18.02% | Avg: $1.17B Low: $1.14B High: $1.20B avg. 9.37% |
FAQ
What is Guardant Health stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 17.67% in 2025-2028.
We have gathered data from 13 analysts. Their low estimate is -381.87M, average is -336.47M and high is -284.44M.
What is Guardant Health stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 23.37% in 2025-2028.
We have gathered data from 17 analysts. Their low revenue estimate is $803.50M, average is $812.66M and high is $824.30M.
What is Guardant Health stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 17.61% in 2025-2028.
We have gathered data from 13 analysts. Their low earnings per share estimate is -$3.41, average is -$2.95 and high is $-2.54.
What is the best performing analyst?
In the last twelve months analysts have been covering Guardant Health stock. The most successful analyst is Subbu Nambi.